Maternal and Fetal Clinical Significance of Hypotension Following Labor Epidural Analgesia

November 26, 2025 updated by: Maxim Glebov, The Chaim Sheba Medical Center

Incidence and Clinical Significance of Maternal Hypotension After Labor Epidural Analgesia and Its Effects on Fetal Well-Being

The goal of this study is to learn how often blood pressure drops after an epidural for labor and how these drops may affect the parent and the baby. The study focuses on adults who give birth at term and choose to receive an epidural for pain relief.

The main questions the study aims to answer are:

How often does maternal blood pressure fall within 30 minutes after the epidural? When blood pressure falls, how often do participants need treatments such as fluids or medicines that raise blood pressure? Do changes in the baby's heart rate happen during this time, and do they need treatment? Are certain parent or labor factors linked to a higher chance of blood pressure drops? How often does an urgent cesarean delivery happen because of maternal low blood pressure or concerning fetal heart rate changes soon after the epidural?

Participants will not be asked to do anything different from usual care. Researchers will:

Review routine vital signs recorded before and after the epidural Review treatments given, such as IV fluids or blood-pressure-raising medicines Review the baby's heart-rate monitoring Record delivery information, including whether an urgent cesarean was needed This study does not change clinical care in any way. It uses information already collected during standard labor and delivery.

Study Overview

Study Type

Observational

Enrollment (Estimated)

480

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Laboring adults who receive epidural analgesia for pain relief at the labor and delivery unit of Sheba Medical Center, a large tertiary hospital in Israel. Participants represent people giving birth at term who choose epidural analgesia as part of their routine clinical care.

Description

Inclusion Criteria:

  • 18 years of age or older
  • 37 weeks pregnant or more (term pregnancy)
  • in labor and choose to receive an epidural for pain relief
  • giving birth at Sheba Medical Center

Exclusion Criteria:

  • patients with a heart condition that requires special blood pressure management
  • medical conditions that prevent safe monitoring of blood pressure
  • missing or incomplete medical record data needed for the study
  • patient who do not receive an epidural during labor

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Laboring Participants Receiving Epidural Analgesia
This cohort includes adults in labor at Sheba Medical Center who choose to receive epidural analgesia for pain relief. All participants receive standard clinical care. Researchers will observe maternal blood pressure and fetal heart rate changes during the first 30 minutes after the epidural.
Participants receive epidural analgesia for labor pain relief as part of routine clinical care at Sheba Medical Center. The epidural involves placement of an epidural catheter, a test dose, and a loading dose of local anesthetic according to hospital protocol. The study does not change how the epidural is performed. Researchers only observe maternal blood pressure and fetal heart rate after epidural placement.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Absolute and relative number of patients with any MAP (mean arterial pressure) < 65 mmHg
Time Frame: First 30 minutes after epidural placement
Hypotension after epidural placement
First 30 minutes after epidural placement

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Absolute and relative number of patients with any MAP (mean arterial pressure) < 60, 55 mmHg
Time Frame: First 30 minutes after epidural placement
Hypotension after epidural placement
First 30 minutes after epidural placement
Absolute and relative number of patients with any SBP (systolic blood pressure) < 90, 85, 80 mmHg
Time Frame: First 30 minutes after epidural placement
Hypotension after epidural placement
First 30 minutes after epidural placement
Incidence of postepidural hypotension defined as ≥20% MAP (mean arterial pressure) drop
Time Frame: First 30 minutes after epidural placement
Hypotension after epidural placement
First 30 minutes after epidural placement
Absolute and relative number of patients with ≥20% SBP (systolic blood pressure) drop
Time Frame: First 30 minutes after epidural placement
Hypotension after epidural placement
First 30 minutes after epidural placement
Time-to-treatment of Hypotension (minutes)
Time Frame: First 30 minutes after epidural placement
The time interval between epidural placement and the treatment of hypotension by clinical staff
First 30 minutes after epidural placement
Area under a MAP of 65, 60, 55 mmHg [mmHg x min]
Time Frame: First 30 minutes after epidural placement
First 30 minutes after epidural placement
Absolute and relative number of patients with symptoms due to hypotension
Time Frame: First 30 minutes after epidural placement
Weakness, lightheadedness, fainting, dizziness, nausea, vomiting
First 30 minutes after epidural placement
Absolute and relative number of patients with NRFHR (Non-reassuring fetal heart rate)
Time Frame: First 30 minutes after epidural placement
First 30 minutes after epidural placement
Absolute and relative number of patients who received fluid bolus
Time Frame: First 30 minutes after epidural placement
First 30 minutes after epidural placement
Absolute and relative number of patients who received vasopressor
Time Frame: First 30 minutes after epidural placement
Phenylephrine, ephedrine
First 30 minutes after epidural placement
Absolute and relative numbers of patients who underwent urgent Cesarean section (Category 1 or 2 urgency) due to hypotension or NRFHR (non-reassuring fetal heart rate)
Time Frame: First 30 minutes after epidural placement
First 30 minutes after epidural placement

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 1, 2025

Primary Completion (Estimated)

February 1, 2026

Study Completion (Estimated)

March 1, 2026

Study Registration Dates

First Submitted

November 18, 2025

First Submitted That Met QC Criteria

November 26, 2025

First Posted (Estimated)

December 9, 2025

Study Record Updates

Last Update Posted (Estimated)

December 9, 2025

Last Update Submitted That Met QC Criteria

November 26, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fetal Heart Rate Abnormalities

Clinical Trials on Epidural Analgesia (Standard Clinical Care)

Subscribe